- Home
- YCBD vs ADXN Comparison
YCBD vs ADXN Comparison
Compare YCBD & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YCBD | ADXN |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | Switzerland |
| Employees | 42 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | YCBD | ADXN |
|---|---|---|
| Price | $0.69 | $6.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 148.8K | 3.4K |
| Earning Date | 05-15-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.70 | $86.57 |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $5.41 |
| 52 Week High | $2.56 | $12.05 |
Technical Indicators
Market Signals| Indicator | YCBD | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 46.72 |
| Support Level | $0.62 | $5.78 |
| Resistance Level | $0.84 | $7.37 |
| Average True Range (ATR) | 0.04 | 0.35 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 14.65 | 31.91 |
Price Performance
Historical ComparisonAbout YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.